Similar Companies
+3 more
Sign in for full access
Short description
Cambridge Cancer Genomics develops precision oncology solutions to transform the way cancer patients are treated.
Description
Cambridge Cancer Genomics develops precision oncology solutions to transform the way cancer patients are treated. Using simple blood draws, CCG shortens the time required to know whether treatment is working, buying the clinician more time to alter treatment and reduce unnecessary side effects. The technology can detect relapse earlier than standard of care, predict response to therapy, and decrease ineffective treatment regimens. Over time, CCG will be able to better predict the best therapeutic strategy for cancer patients before they even begin treatment.
Cambridge Cancer Genomics was founded on 2016 and is headquartered in Cambridge, England.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Cambridge, Cambridgeshire, United Kingdom, Europe
Founded on
January 1, 2016
Exited on
June 23, 2021
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Investors
Absolutely Noaccess, Noway Youcantaccess, Absolutely Noaccess, Uh Ohhhh, Noaccessforu, Noaccess, Absolutely Noaccess, Absolutely Noaccess, Noaccess, Absolutely Noaccess
Sign in for full access
Founders
Evaline Tsai, Harry Clifford, John Cassidy, Nirmesh Patel